Category: <span>mesothelioma</span>

Category: mesothelioma

immunotherapy clinical trial, immunotherapy for cancer, mesothelioma, mesothelioma clinical trials, mesothelioma immunotherapy, Mesothelioma News, ONCOS 102

ONCOS-102 Mesothelioma Clinical Trial Promises Hope

 

Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with…

The post ONCOS-102 Mesothelioma Clinical Trial Promises Hope appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

immunotherapy clinical trial, immunotherapy for cancer, mesothelioma, mesothelioma clinical trials, mesothelioma immunotherapy, Mesothelioma News, ONCOS 102

ONCOS-102 Mesothelioma Clinical Trial Promises Hope

 

Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with…

The post ONCOS-102 Mesothelioma Clinical Trial Promises Hope appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

immunotherapy clinical trial, immunotherapy for cancer, mesothelioma, mesothelioma clinical trials, mesothelioma immunotherapy, Mesothelioma News, ONCOS 102

ONCOS-102 Mesothelioma Clinical Trial Promises Hope

 

Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with…

The post ONCOS-102 Mesothelioma Clinical Trial Promises Hope appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

cancer surgery, cancer treatment, mesothelioma, Mesothelioma News, mesothelioma surgery, Mesothelioma treatment, Wickii Vigneswaran

Mesothelioma Surgery Improves Quality of Life

 

Renowned thoracic surgeon Dr. Wickii Vigneswaran in Chicago believes far too many patients with pleural mesothelioma are being denied aggressive surgeries that could improve their quality of life. He wants to fix that dilemma. Vigneswaran, a mesothelioma specialist at the Loyola University Medical Center, authored a recent study debunking the long-standing belief that major surgery…

The post Mesothelioma Surgery Improves Quality of Life appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

comedian quincy jones, HBO, hbo special burning the light, mesothelioma, Mesothelioma News, quincy jones

Quincy Jones Talks Mesothelioma in HBO’s ‘Burning the Light’

 

Last night, comedian Quincy Jones opened his heart to HBO viewers with “Quincy Jones: Burning the Light,” a one-hour special about his personal battle with mesothelioma. “There is no cancer when I am on that stage,” the 31-year-old told the audience at the Teragram Ballroom in Los Angeles. “It is only me telling my jokes….

The post Quincy Jones Talks Mesothelioma in HBO’s ‘Burning the Light’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.